We utilized single-cell genomics to characterize a T-ALL patient treated on COG AALL0434 with a poor clinical outcome despite favorable genomic features, identifying a STAT1-mediated interferon-related transcriptional signature and an inflammatory microenvironment that was associated with sensitivity to small molecule JAK-inhibition.
Subjects:
Lymphoid Neoplasia
This content is only available as a PDF.
Copyright © 2025 American Society of Hematology
2025
You do not currently have access to this content.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal